Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (Aug 11, 1999)

Reports
Other Events
Filing Date
Filed August 11, 1999
Period End
August 11, 1999
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed August 11, 1999. Cited figures are marked; the original filing is the authoritative source.

On August 11, 1999, The Procter & GambleCompany (PG) filed a Form 8-K under Item 5 (Other Events) to disclose that on August 2, 1999, it entered into a Share Purchase Agreement with The Iams Company and its affiliates and shareholders.

The filing attaches a joint press release from P&G and Iams dated August 11, 1999, which is the main source of deal detail. The 8-K text itself does not state the purchase price, consideration, financing, or expected closing timeline, so investors should review the press release and any subsequent filings for those terms. The transaction matters because it would expand P&G's pet food business, an area where Iams was a premium brand.

An acquisition of this type typically adds revenue and brand assets, but it also brings integration risk, possible balance-sheet and earnings effects from financing or goodwill, and regulatory review. Because the agreement was signed on August 2 and announced on August 11, the disclosure timing suggests the parties were coordinating a public announcement after signing. For investors, the key points are the existence and date of the agreement and the strategic direction it signals.

The filing alone is not enough to assess valuation or accretion. Those questions depend on the purchase price, the Iams financial profile, and the closing conditions, which should be checked in the attached press release and related regulatory filings.

Key Highlights

  1. P&G entered into a Share Purchase Agreement with The Iams Company, its affiliates, and Iams shareholders on August 2, 1999.
  2. The 8-K was filed August 11, 1999, under Item 5 (Other Events) and attaches a joint P&G/Iams press release dated the same day.
  3. The filing does not disclose purchase price, form of consideration, or financing terms; these must be taken from the press release or later filings.
  4. The transaction signals a strategic expansion of P&G's pet food business through the acquisition of a premium pet nutrition brand.
  5. Closing is subject to customary conditions and possibly regulatory review; the filing does not specify the expected closing date.
  6. The disclosure was made as a material event, indicating the agreement was significant enough to report to shareholders and the SEC.

Frequently Asked Questions

  1. What did P&G actually agree to do?

    P&G entered into a Share Purchase Agreement on August 2, 1999, with The Iams Company, its affiliates, and Iams's shareholders. The agreement provides for P&G to acquire Iams, as described in the attached joint press release.

  2. How much is P&G paying for Iams?

    The 8-K excerpt does not state the price. Investors should check the attached joint press release and P&G's subsequent SEC filings for the purchase price and payment terms.

  3. Why does this acquisition matter to P&G investors?

    It moves P&G further into pet nutrition, a category with premium brand economics. Whether it is value-creating depends on the price paid, Iams's growth and margins, and integration execution, none of which are detailed in this filing.

  4. Is the deal complete?

    Not as of this filing. An 8-K announcing a signed agreement is typically followed by closing, which depends on conditions such as shareholder approval, regulatory clearance, and other customary requirements. The filing does not give a closing date.

  5. What should investors watch for next?

    Watch for the disclosed purchase price and financing, any regulatory filings, the closing announcement, and P&G's guidance on the deal's expected effect on earnings and integration costs.